2019
DOI: 10.1111/pde.13838
|View full text |Cite
|
Sign up to set email alerts
|

Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test

Abstract: Acute generalized exanthematous pustulosis (AGEP) is seen uncommonly in children and sometimes shows atypical clinical features in this population. Patch testing can be used effectively in children for the confirmation of the culprit drug in cases of multiple drug use. Here, we report a rare, pediatric case of ceftriaxone‐induced AGEP confirmed by patch testing with subsequent recurrence of the skin eruption.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
15
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 14 publications
1
15
0
Order By: Relevance
“…The widespread micropustules were also found on the patch test reactions to thioureas, suggesting the same cellular pathogenesis was involved at the local patch test site than at the systemic level. During histopathological analysis, the observed pustular spongiosis is consistent with a subtype of ACD not usually found in AGEP 4,5 …”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…The widespread micropustules were also found on the patch test reactions to thioureas, suggesting the same cellular pathogenesis was involved at the local patch test site than at the systemic level. During histopathological analysis, the observed pustular spongiosis is consistent with a subtype of ACD not usually found in AGEP 4,5 …”
Section: Discussionsupporting
confidence: 79%
“…During histopathological analysis, the observed pustular spongiosis is consistent with a subtype of ACD not usually found in AGEP. 4,5…”
Section: Discussionmentioning
confidence: 99%
“…No HCQ‐induced AGEP cases have been reported among the 45 patients with AGEP 23 . Drug patch testing in patients with AGEP is considered safe, although relapse during patch testing has been reported 24 . This test was performed in three of our patients, showing a positive result in only one case.…”
Section: Discussionmentioning
confidence: 64%
“…23 Drug patch testing in patients with AGEP is considered safe, although relapse during patch testing has been reported. 24 This test was performed in three of our patients, showing a positive result in only one case. Value and safety of Intradermal reaction and prick testing in AGEP are unknown, but systemic provocation of suspected drug or cross-reactive drugs is contraindicated.…”
Section: Discussionmentioning
confidence: 70%
“…AGEP has been linked with many medications, including teicoplanin and lopinanvir that were taken by the patient, but infections may also be occasional triggers 4–7 . Patch testing is often positive in AGEP with confirmation of the culprit drug; however, it can cause recurrence of the skin eruption 8 …”
Section: Figurementioning
confidence: 99%